Review of guideline for the management of large vessel vasculitis presented in 2021 by the American College of Rheumatology / Vasculitis Foundation
Open Access
- 14 May 2022
- journal article
- review article
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 60 (2), 165-173
- https://doi.org/10.47360/1995-4484-2022-165-173
Abstract
The main statements of the recommendations of the American College of Rheumatology and the Vasculitis Foundation on the treatment of patients with systemic vasculitis of large vessels, published in August 2021, are discussed. As a result of a detailed review of current data, a group of experts proposed 22 recommendations and 2 ungraded position statements for giant cell arteritis (GCA), as well as 20 recommendations and 1 ungraded position statement for Takayasu arteritis (AT), on the basis of which algorithms for the treatment of patients with these diseases are presented. An expansion of the value of genetically engineered biological therapy, primarily tocilizumab in GCA and tumour necrosis factor alpha inhibitors in AT, has been recorded. The new recommendations should not be considered as final standards, but are intended to become the basis for choosing a personalized treatment strategy for patients with large vessels vasculitis and serve as a starting point for further research.Keywords
This publication has 51 references indexed in Scilit:
- Does preoperative steroid treatment affect the histology in giant cell (cranial) arteritis?Journal of Clinical Pathology, 2012
- Tumor necrosis factor inhibitors in patients with Takayasu arteritis: Experience from a referral center with long‐term followupArthritis Care & Research, 2012
- Association of Vascular Physical Examination Findings and Arteriographic Lesions in Large Vessel VasculitisThe Journal of Rheumatology, 2011
- Surgical management of ascending aortic aneurysm due to non-infectious aortitisScandinavian Cardiovascular Journal, 2008
- Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritisAnnals Of The Rheumatic Diseases, 2006
- Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better?Annals Of The Rheumatic Diseases, 2006
- Takayasu’s arteritis: Operative results and influence of disease activityJournal of Vascular Surgery, 2006
- Post-interventional immunosuppressive treatment and vascular restenosis in Takayasu's arteritisRheumatology, 2005
- Treatment with statins does not exhibit a clinically relevant corticosteroid‐sparing effect in patients with giant cell arteritisArthritis Care & Research, 2004
- Percutaneous transluminal angioplasty in Takayasu arteritisHeart and Vessels, 1992